Virus-based gene therapy research
Virus-based gene therapy research is a research topic within Genetics. Science Explorer counts 72k research works in it since 1950. 24.3% of them reached the world's top 10% most cited for their field and year.
This cluster of papers covers a wide range of topics related to gene therapy, including the use of viral vectors such as AAV and adenovirus, advancements in oncolytic virus therapy, hematopoietic stem cell gene therapy, immunodeficiency treatments, lentiviral vector applications, transgene expression, and genomic integration. The research reflects the ongoing progress and challenges in the field of gene therapy.
- Gene Therapy
- Viral Vectors
- AAV
- Oncolytic Virus
- Hematopoietic Stem Cell
- Immunodeficiency
- Lentiviral Vector
- Adenovirus
- Transgene Expression
- Genomic Integration
- Research works
- 72k fractional, since 1950
- In the world top 10%
- 17k per year above
- Top-10% rate
- 24.3% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +6% the tick is no change
Which countries lead Virus-based gene therapy research research?
By volume, the United States and China publish the most (2.3k and 1.9k works in 2022–2025).
By volume, 2022–2025
- 1 United States 2.3k works
- 2 China 1.9k works
- 3 Germany 385 works
- 4 Japan 357 works
- 5 India 314 works
- 6 United Kingdom 299 works
- 7 Italy 234 works
- 8 France 207 works
- 9 South Korea 205 works
- 10 Brazil 199 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Virus-based gene therapy research research?
By volume in 2022–2025, University of Pennsylvania publishes the most Virus-based gene therapy research research, followed by University of North Carolina at Chapel Hill and Yangzhou University.
By volume, 2022–2025
- 1 University of PennsylvaniaUnited States 44 works
- 2 University of North Carolina at Chapel HillUnited States 41 works
- 3 Yangzhou UniversityChina 36 works
- 4 Chinese Academy of Agricultural SciencesChina 34 works
- 5 Harvard UniversityUnited States 33 works
- 6 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 32 works
- 7 The University of Texas MD Anderson Cancer CenterUnited States 29 works
- 8 Sichuan UniversityChina 27 works
- 9 University of MinnesotaUnited States 27 works
- 10 South China Agricultural UniversityChina 26 works
Who are the leading researchers in Virus-based gene therapy research?
The most-cited researchers publishing on Virus-based gene therapy research include Dirk Schadendorf and Róbert Langer.
- 1 Dirk Schadendorf Germany 4.4k citations
- 2 Róbert Langer United States 4.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Virus-based gene therapy research research done?
The largest centres of Virus-based gene therapy research research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Wuhan (China).
Largest cities, 2022–2025
Where is the best place to study Virus-based gene therapy research?
Among universities, judged by research, University of Massachusetts Chan Medical School, University of Pennsylvania and Harvard University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | University of Massachusetts Chan Medical SchoolUnited States | 69.3 | 51.9% | 12.8× | 16 | +41.9% |
| 2 | University of PennsylvaniaUnited States | 62.5 | 40.8% | 5.9× | 44 | +10.3% |
| 3 | Harvard UniversityUnited States | 53.2 | 37.8% | 3.2× | 33 | +6.8% |
| 4 | Huazhong Agricultural UniversityChina | 50.5 | 19.2% | 9.2× | 26 | -2.0% |
| 5 | South China Agricultural UniversityChina | 50.2 | 25.8% | 8.9× | 26 | -37.8% |
| 6 | Henan Agricultural UniversityChina | 49.6 | 19.1% | 15.2× | 21 | +13.6% |
| 7 | University College LondonUnited Kingdom | 48.9 | 39.3% | 2.1× | 23 | +12.6% |
| 8 | Henan Medical UniversityChina | 48.6 | 13.3% | 16.1× | 10 | +223.3% |
| 9 | Yangzhou UniversityChina | 48.3 | 20.4% | 7.8× | 36 | -34.8% |
| 10 | Duke UniversityUnited States | 48.1 | 34.0% | 3.7× | 21 | +87.2% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Virus-based gene therapy research research growing?
Output in 2018–2022 was 6% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Virus-based gene therapy research.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.